Definition of Yttrium Y 90 Daclizumab

A synthetic radioimmunoconjugate comprised of a humanized anti-interleukin-2 (IL-2) antibody linked to the radioisotope yttrium 90 with potential antineoplastic activity. daclizumab binds with high affinity to the Tac (also called CD25) subunit of the IL-2 receptor complex and inhibits the binding of IL-2, thereby blocking the IL-2-mediated activation of lymphocytes. As yttrium Y 90 daclizumab, daclizumab delivers radiation specifically to lymphocytes that express the IL-2 receptor. (NCI04)

Yttrium Y 90 Daclizumab is from the group

Radioimmunoconjugate

Other Names for Yttrium Y 90 Daclizumab

Yttrium Y 90 Daclizumab
Y90 Daclizumab
Y90 MOAB Anti-Tac

Source

NCI Thesaurus License

Topics #Yttrium Y 90 Daclizumab Y90 Daclizumab Y90 MOAB Anti-Tac